Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line

This publication has 26 references indexed in Scilit:

• Dysregulation of tyrosine kinases and use of imatinib in small animal practice
  The Veterinary Journal, 2015
• Analysis of drug combinations: current methodological landscape
  Pharmacology Research & Perspectives, 2015
• Chemotherapy and remission status do not alter pre-existing innate immune dysfunction in dogs with lymphoma
  Research in Veterinary Science, 2014
• Multiple Drug Resistance Mechanisms in Cancer
  Molecular Biotechnology, 2010
• Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma
  Leukemia Research, 2010
• Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells
  Lung Cancer, 2005
• Distinct B-Cell and T-Cell Lymphoproliferative Disease Prevalence among Dog Breeds Indicates Heritable Risk
  Cancer Research, 2005
• Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance
  Cancer Chemotherapy and Pharmacology, 2003
• Multidrug resistance ABC transporters
  FEBS Letters, 2003
• Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells
  Cancer Science, 2003